Published in Hum Mutat on December 20, 2012
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol (2013) 2.54
Honokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosis. PLoS One (2014) 0.88
The protein corona protects against size- and dose-dependent toxicity of amorphous silica nanoparticles. Beilstein J Nanotechnol (2014) 0.80
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol (2013) 2.54
Acetylation of Stat1 modulates NF-kappaB activity. Genes Dev (2006) 2.10
A phosphorylation-acetylation switch regulates STAT1 signaling. Genes Dev (2009) 1.98
Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano (2011) 1.90
Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. Cancer Res (2003) 1.44
The Survivin-Crm1 interaction is essential for chromosomal passenger complex localization and function. EMBO Rep (2006) 1.40
Nuclear export is essential for the tumor-promoting activity of survivin. FASEB J (2006) 1.25
Cytokines in head and neck cancer. Cytokine Growth Factor Rev (2006) 1.24
Impact of the nanoparticle-protein corona on colloidal stability and protein structure. Langmuir (2012) 1.15
The survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex protein. Cell Cycle (2007) 1.11
B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells. Blood (2002) 1.08
Survivin's dual role: an export's view. Cell Cycle (2007) 1.07
Tumor-specific glycosylation of the carcinoma-associated epithelial cell adhesion molecule EpCAM in head and neck carcinomas. Cancer Lett (2003) 1.06
Glandular tissue from human pancreas and salivary gland yields similar stem cell populations. Eur J Cell Biol (2009) 1.06
Patient-based cross-platform comparison of oligonucleotide microarray expression profiles. Lab Invest (2005) 1.05
Isolation and characterization of adult stem cells from human salivary glands. Stem Cells Dev (2008) 1.05
Understanding and exploiting nanoparticles' intimacy with the blood vessel and blood. Chem Soc Rev (2015) 1.05
NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas. Cancer Res (2008) 1.02
A case of central sleep apnea strictly dependent upon REM-sleep. J Neurol (2010) 1.02
Nuclear export is evolutionarily conserved in CVC paired-like homeobox proteins and influences protein stability, transcriptional activation, and extracellular secretion. Mol Cell Biol (2005) 1.02
Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin. Int J Cancer (2009) 1.01
Role of cytokines in head and neck squamous cell carcinoma. Expert Rev Anticancer Ther (2006) 1.01
Application of the Vibrant Soundbridge to unilateral osseous atresia cases. Laryngoscope (2009) 1.01
Cell-based analysis of structure-function activity of threonine aspartase 1. J Biol Chem (2010) 0.98
Histamine upregulates gene expression of endothelial nitric oxide synthase in human vascular endothelial cells. Circulation (2003) 0.98
Analysis of plasmacytoid and myeloid dendritic cells in nasal epithelium. Clin Vaccine Immunol (2006) 0.97
Translocation biosensors to study signal-specific nucleo-cytoplasmic transport, protease activity and protein-protein interactions. Traffic (2005) 0.96
Innate signaling in otitis media: pathogenesis and recovery. Curr Allergy Asthma Rep (2011) 0.96
The role of DNA sensing and innate immune receptor TLR9 in otitis media. Innate Immun (2011) 0.94
A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer. Oncotarget (2012) 0.94
Stem cells in squamous head and neck cancer. Crit Rev Oncol Hematol (2011) 0.94
MYC directs transcription of MCL1 and eIF4E genes to control sensitivity of gastric cancer cells toward HDAC inhibitors. Cell Cycle (2012) 0.94
Permanent up-regulation of regulatory T-lymphocytes in patients with head and neck cancer. Int J Mol Med (2010) 0.93
Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer. In Vivo (2008) 0.93
Nucleocytoplasmic shuttling and the biological activity of mouse survivin are regulated by an active nuclear export signal. Traffic (2006) 0.93
Application of the Vibrant Soundbridge in bilateral congenital atresia in toddlers. Acta Otolaryngol (2010) 0.91
Dynamically regulated sumoylation of HDAC2 controls p53 deacetylation and restricts apoptosis following genotoxic stress. J Mol Cell Biol (2012) 0.90
The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target. Strahlenther Onkol (2007) 0.90
Tumour-derived prostaglandin E and transforming growth factor-beta synergize to inhibit plasmacytoid dendritic cell-derived interferon-alpha. Immunology (2009) 0.90
The Lübeck flowchart for functional and aesthetic rehabilitation of aural atresia and microtia. Otol Neurotol (2012) 0.90
Bioassays to monitor Taspase1 function for the identification of pharmacogenetic inhibitors. PLoS One (2011) 0.89
Identification of two nuclear import signals in the alpha-gene product ICP22 of herpes simplex virus 1. Virology (2002) 0.89
Decreased levels of circulating regulatory NK cells in patients with head and neck cancer throughout all tumor stages. Anticancer Res (2009) 0.89
Impaired monocyte function in cancer patients: restoration with a cyclooxygenase-2 inhibitor. FASEB J (2002) 0.89
Dynamic survivin in head and neck cancer: molecular mechanism and therapeutic potential. Int J Cancer (2007) 0.88
Histone deacetylase inhibitors block IFNγ-induced STAT1 phosphorylation. Cell Signal (2012) 0.88
Development of an autofluorescent translocation biosensor system to investigate protein-protein interactions in living cells. Anal Chem (2005) 0.88
The Oral Serine Protease Inhibitor WX-671 - First Experience in Patients with Advanced Head and Neck Carcinoma. Breast Care (Basel) (2008) 0.87
Nuclear receptors in head and neck cancer: current knowledge and perspectives. Int J Cancer (2010) 0.87
Increased cytokine secretion in head and neck cancer upon p38 mitogen-activated protein kinase activation. Int J Mol Med (2007) 0.86
Inflammatory pseudotumor of the hypopharynx: clinical diagnosis, immunohistochemical findings and treatment of this rare disease. In Vivo (2009) 0.86
Yeast Gcn4p stabilization is initiated by the dissociation of the nuclear Pho85p/Pcl5p complex. Mol Biol Cell (2006) 0.86
miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating Survivin. Int J Cancer (2014) 0.84
Sleep apnoea in patients after treatment of head neck cancer. Acta Otolaryngol (2009) 0.84
Cytokine changes in response to radio-/chemotherapeutic treatment in head and neck cancer. Anticancer Res (2013) 0.84
Metastases of squamous cell carcinoma of the head and neck show increased levels of nucleotide excision repair protein XPF in vivo that correlate with increased chemoresistance ex vivo. Int J Oncol (2010) 0.84
Induction of c-Myc-dependent cell proliferation through toll-like receptor 3 in head and neck cancer. Int J Mol Med (2008) 0.84
No king without a crown--impact of the nanomaterial-protein corona on nanobiomedicine. Nanomedicine (Lond) (2015) 0.84
The differentiation antigen NY-BR-1 is a potential target for antibody-based therapies in breast cancer. Int J Cancer (2007) 0.83
Established and novel NF-κB inhibitors lead to downregulation of TLR3 and the proliferation and cytokine secretion in HNSCC. Oral Oncol (2011) 0.83
Secretion of tumor-promoting and immune suppressive cytokines by cell lines of head and neck squamous cell carcinoma. In Vivo (2006) 0.83
Fast alterations of vascular endothelial growth factor (VEGF) expression and that of its receptors (Flt-1, Flk-1 and Neuropilin) in the cochlea of guinea pigs after moderate noise exposure. Eur Arch Otorhinolaryngol (2006) 0.83
Activated B cells mediate efficient expansion of rare antigen-specific T cells. Hum Immunol (2007) 0.83
Akt and c-Jun N-terminal kinase are regulated in response to moderate noise exposure in the cochlea of guinea pigs. ORL J Otorhinolaryngol Relat Spec (2007) 0.82
LPS-induced mucin expression in human sinus mucosa can be attenuated by hCLCA inhibitors. J Endotoxin Res (2007) 0.82
Head and neck cancer triggers increased IL-6 production of CD34+ stem cells from human cord blood. In Vivo (2007) 0.82
mTOR inhibitors show promising in vitro activity in bladder cancer and head and neck squamous cell carcinoma. Oncol Rep (2011) 0.82
Phosphorylation of STAT3 in head and neck cancer requires p38 MAPKinase, whereas phosphorylation of STAT1 occurs via a different signaling pathway. Anticancer Res (2011) 0.81
Time-of-flight magnetic flow cytometry in whole blood with integrated sample preparation. Lab Chip (2013) 0.81
Cartilage tissue engineering using resorbable scaffolds. J Tissue Eng Regen Med (2008) 0.81
Allosteric inhibition of Taspase1's pathobiological activity by enforced dimerization in vivo. FASEB J (2012) 0.81
An update on the pathobiological relevance of nuclear receptors for cancers of the head and neck. Histol Histopathol (2010) 0.81